Meyer Markus, Núñez Julio, Goyal Parag, Silverman Daniel N, van Berlo Jop H, Maharaj Valmiki
Lillehei Heart Institute, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
Cardiology Department, Hospital Clínico Universitario, INCLIVA, Universitat de València, València 46010, Spain.
J Cardiovasc Aging. 2024 Dec;4(4). doi: 10.20517/jca.2024.22. Epub 2024 Dec 23.
The age-related decline in diastolic function can result in heart failure with a preserved ejection fraction (HFpEF) and atrial fibrillation (AF), which are comorbid conditions that are increasingly prevalent and have a high socioeconomic burden. In humans, diastolic dysfunction results from structural and functional changes that increasingly impede diastolic filling after midlife. Comorbidities and pathomechanisms that lead to additional increases in cardiac filling pressures accelerate the age-related deterioration in diastolic function. It is, therefore, that targeting the accelerators of diastolic dysfunction holds the most promise in reducing the risk for HFpEF and AF.
舒张功能随年龄增长而下降可导致射血分数保留的心力衰竭(HFpEF)和心房颤动(AF),这两种合并症日益普遍,且具有很高的社会经济负担。在人类中,舒张功能障碍是由结构和功能变化引起的,这些变化在中年以后越来越阻碍舒张期充盈。导致心脏充盈压进一步升高的合并症和病理机制会加速舒张功能随年龄增长的恶化。因此,针对舒张功能障碍的加速因素最有希望降低HFpEF和AF的风险。